Endpoints News 1 abr 2026 Novo cuts 400 jobs in Indiana as Scholar Rock refiles drug linked to the factory
Endpoints News 1 abr 2026 Lilly wins approval of anti-obesity pill orforglipron, setting up new battle with Novo
Endpoints News 1 abr 2026 Paragon offshoot Korsana to go public in reverse merger for Alzheimer's work
Endpoints News 1 abr 2026 IO Biotech will file for bankruptcy after failure of cancer vaccine in key trial
Endpoints News 1 abr 2026 Oric to advance prostate cancer drug to Phase 3, but combo choice raises doubts
Endpoints News 31 mar 2026 AstraZeneca's next-gen hopeful for a rare bone condition fails pivotal trial
Endpoints News 31 mar 2026 Astellas doesn’t pick up AviadoBio’s gene therapy, but nonprofit funding will move it forward